BrainsWay Cash And Equivalents vs. Revenue

BRSYF Stock  USD 8.53  0.00  0.00%   
Based on the key profitability measurements obtained from BrainsWay's financial statements, BrainsWay may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess BrainsWay's ability to earn profits and add value for shareholders.
For BrainsWay profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BrainsWay to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BrainsWay utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BrainsWay's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BrainsWay over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.
Please note, there is a significant difference between BrainsWay's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrainsWay is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrainsWay's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BrainsWay Revenue vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BrainsWay's current stock value. Our valuation model uses many indicators to compare BrainsWay value to that of its competitors to determine the firm's financial worth.
BrainsWay is number one stock in cash and equivalents category among its peers. It also is the top company in revenue category among its peers totaling about  0.57  of Revenue per Cash And Equivalents. The ratio of Cash And Equivalents to Revenue for BrainsWay is roughly  1.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BrainsWay's earnings, one of the primary drivers of an investment's value.

BrainsWay Revenue vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

BrainsWay

Cash

 = 

Bank Deposits

+

Liquidities

 = 
52.45 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

BrainsWay

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
29.66 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

BrainsWay Revenue vs Competition

BrainsWay is the top company in revenue category among its peers. Market size based on revenue of Medical Devices industry is currently estimated at about 32.59 Million. BrainsWay totals roughly 29.66 Million in revenue claiming about 91% of all equities under Medical Devices industry.

BrainsWay Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BrainsWay, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BrainsWay will eventually generate negative long term returns. The profitability progress is the general direction of BrainsWay's change in net profit over the period of time. It can combine multiple indicators of BrainsWay, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.

BrainsWay Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BrainsWay. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BrainsWay position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BrainsWay's important profitability drivers and their relationship over time.

Use BrainsWay in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BrainsWay position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrainsWay will appreciate offsetting losses from the drop in the long position's value.

BrainsWay Pair Trading

BrainsWay Pair Trading Analysis

The ability to find closely correlated positions to BrainsWay could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BrainsWay when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BrainsWay - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BrainsWay to buy it.
The correlation of BrainsWay is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BrainsWay moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BrainsWay moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BrainsWay can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BrainsWay position

In addition to having BrainsWay in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in BrainsWay Pink Sheet

When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
Check out Trending Equities.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
To fully project BrainsWay's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BrainsWay at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BrainsWay's income statement, its balance sheet, and the statement of cash flows.
Potential BrainsWay investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BrainsWay investors may work on each financial statement separately, they are all related. The changes in BrainsWay's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BrainsWay's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.